These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 27297501)
21. Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency. Paragliola RM; Perrucci A; Foca L; Urbani A; Concolino P J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807105 [TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-β (TGF-β) pathway abnormalities in tenascin-X deficiency associated with CAH-X syndrome. Morissette R; Merke DP; McDonnell NB Eur J Med Genet; 2014 Feb; 57(2-3):95-102. PubMed ID: 24380766 [TBL] [Abstract][Full Text] [Related]
23. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia. Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250 [TBL] [Abstract][Full Text] [Related]
24. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Mao JR; Taylor G; Dean WB; Wagner DR; Afzal V; Lotz JC; Rubin EM; Bristow J Nat Genet; 2002 Apr; 30(4):421-5. PubMed ID: 11925569 [TBL] [Abstract][Full Text] [Related]
25. Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera. Lao Q; Burkardt DD; Kollender S; Faucz FR; Merke DP Mol Genet Genomic Med; 2023 Jul; 11(7):e2195. PubMed ID: 37157918 [TBL] [Abstract][Full Text] [Related]
26. Congenital adrenal hyperplasia, ovarian failure and Ehlers-Danlos syndrome due to a 6p deletion. Moysés-Oliveira M; Mancini TI; Takeno SS; Rodrigues AD; Bachega TA; Bertola D; Melaragno MI Sex Dev; 2014; 8(4):139-45. PubMed ID: 24970489 [TBL] [Abstract][Full Text] [Related]
27. An overlapping phenotype of Osteogenesis imperfecta and Ehlers-Danlos syndrome due to a heterozygous mutation in COL1A1 and biallelic missense variants in TNXB identified by whole exome sequencing. Mackenroth L; Fischer-Zirnsak B; Egerer J; Hecht J; Kallinich T; Stenzel W; Spors B; von Moers A; Mundlos S; Kornak U; Gerhold K; Horn D Am J Med Genet A; 2016 Apr; 170A(4):1080-5. PubMed ID: 26799614 [TBL] [Abstract][Full Text] [Related]
28. Recurrent pneumothorax in a case of tenascin-X deficient Ehlers-Danlos syndrome: Broadening the phenotypic spectrum. Santoreneos R; Vakulin C; Ellul M; Rawlings L; Hardy T; Poplawski N Am J Med Genet A; 2022 May; 188(5):1583-1588. PubMed ID: 35128805 [TBL] [Abstract][Full Text] [Related]
29. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. Schalkwijk J; Zweers MC; Steijlen PM; Dean WB; Taylor G; van Vlijmen IM; van Haren B; Miller WL; Bristow J N Engl J Med; 2001 Oct; 345(16):1167-75. PubMed ID: 11642233 [TBL] [Abstract][Full Text] [Related]
30. Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel Rymen D; Ritelli M; Zoppi N; Cinquina V; Giunta C; Rohrbach M; Colombi M Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31731524 [TBL] [Abstract][Full Text] [Related]
31. Compound heterozygosity for TNXB genetic variants in a mixed-breed dog with Ehlers-Danlos syndrome. Bauer A; de Lucia M; Leuthard F; Jagannathan V; Leeb T Anim Genet; 2019 Oct; 50(5):546-549. PubMed ID: 31365140 [TBL] [Abstract][Full Text] [Related]
32. Tenascin-X, collagen, and Ehlers-Danlos syndrome: tenascin-X gene defects can protect against adverse cardiovascular events. Petersen JW; Douglas JY Med Hypotheses; 2013 Sep; 81(3):443-7. PubMed ID: 23830591 [TBL] [Abstract][Full Text] [Related]
33. PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module. Lee HH; Lee YJ; Lin CY Genomics; 2004 May; 83(5):944-50. PubMed ID: 15081125 [TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of the new clinical entity associated with congenital adrenal hyperplasia: the CAH-X syndrome in the Spanish population. Figueras LM; Pacheco RM; González DG; Domènech MA; Zubicaray BE Adv Lab Med; 2023 Sep; 4(3):258-267. PubMed ID: 38075167 [TBL] [Abstract][Full Text] [Related]
35. Biallelic mutations in Tenascin-X cause classical-like Ehlers-Danlos syndrome with slowly progressive muscular weakness. Brisset M; Metay C; Carlier RY; Badosa C; Marques C; Schalkwijk J; vanVlijmen-Willems I; Jimenez-Mallebrera C; Keren B; Jobic V; Laforêt P; Malfatti E Neuromuscul Disord; 2020 Oct; 30(10):833-838. PubMed ID: 32988710 [TBL] [Abstract][Full Text] [Related]
36. Recognizing the tenascin-X deficient type of Ehlers-Danlos syndrome: a cross-sectional study in 17 patients. Demirdas S; Dulfer E; Robert L; Kempers M; van Beek D; Micha D; van Engelen BG; Hamel B; Schalkwijk J; Loeys B; Maugeri A; Voermans NC Clin Genet; 2017 Mar; 91(3):411-425. PubMed ID: 27582382 [TBL] [Abstract][Full Text] [Related]
37. A rare CYP21A2 haplotype clarifies the phenotype-genotype discrepancy in an Italian patient with Non Classical Congenital Adrenal Hyperplasia (NC-CAH). Concolino P Mol Biol Rep; 2020 Apr; 47(4):3049-3052. PubMed ID: 32185686 [TBL] [Abstract][Full Text] [Related]
38. Unusual Combination of MEN-1 and the Contiguous Gene Deletion Syndrome of CAH and Ehlers-Danlos Syndrome (CAH-X). Chen Cardenas SM; El-Kaissi S; Jarad O; Liaqat M; Korbonits M; Hamrahian AH J Endocr Soc; 2020 Aug; 4(8):bvaa077. PubMed ID: 32715272 [TBL] [Abstract][Full Text] [Related]
39. Molecular basis and genetic testing strategies for diagnosing 21-hydroxylase deficiency, including CAH-X syndrome. Kim JH; Kim GH; Yoo HW; Choi JH Ann Pediatr Endocrinol Metab; 2023 Jun; 28(2):77-86. PubMed ID: 37401054 [TBL] [Abstract][Full Text] [Related]